Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change
Table 2
Clinical, biological, and echocardiographic parameters of the 9 patients with treatment change induced by echocardiography.
Patients
1
2
3
4
5
6
7
8
9
Age (years)
56
54
82
76
64
74
62
59
66
Gender
M
M
F
M
F
M
M
M
F
COVID-19 diagnosis
Chest CT
Chest CT + NP swab
Pneumonia
Chest CT + NP swab
Chest CT + NP swab
NP swab
Chest CT + NP swab
Chest CT
Chest CT
Severity of symptoms
Intubated
Intubated
Need for oxygen
Intubated
Intubated
Intubated
Need for oxygen
Need for oxygen
Intubated
Initial symptoms
Ischemic stroke
Resp. distress
Stroke + Resp. distress
Resp. distress
Resp. distress
Resp. distress
Resp. distress
Resp. distress
Viral syndrome
Indication for TTE/TEE
Stroke + hemodynamic
LV function/hemodynamic
Stroke + hemodynamic
LV FP
LV FP
Hemodynamic
ACS ST-
LV function/hemodynamic
Resp. distress
LVEF (%)
>50
>50
52
76
83
>50
47
59
69
E/Ea
7
NA
16
9.2
8.5
NA
10.4
5.1
6.7
RV dilatation
0
1
0
0
0
1
0
0
0
PAPs (mmHg)
35
80
NA
40
39
55
NA
42
38
Echo finding inducing the modification
Inferior wall MI
RA thrombus
RA thrombus
Not elevated LV FP
Low LV FP
Right pulmonary artery thrombus
Akinesia
Aortic aneurysm
Normal LV, low LV FP
Treatment change
DAPT
Thrombolysis (PE)
AC
Stop diuretics
Fluid administration
NFH
DAPT
ß bloq
Stop IV nitrates
Known CVD
No
No
Yes
Yes
No
No
No
No
No
HTN
No
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Diabetes
Yes
No
No
No
No
Yes
Yes
No
No
Body area (m2)
2.06
2.35
1.87
2.19
1.75
1.97
1.92
1.83
1.69
BMI (Kg/.m2)
29.3
34.0
26.7
31.3
34.9
29.6
27.0
31.2
29.1
Hs Troponin T (pg/ml)
776,9
9.3
105.2
101.5
53.6
112.2
172.8
30.3
8.9
NT-pro BNP (pg/ml)
750
206
15652
219
2808
6119
4038
339
370
D-dimer (ng/ml)
20000
5670
20000
2690
1550
20000
2590
20000
20000
Fibrinogen (g/l)
1.2
8
5.7
4.4
12
5.2
12
7.2
8
Blood type
O+
AB+
NA
B−
NA
O+
O+
O+
A−
Evolution#
Discharge
Still in hospital (ECMO)
Deceased
Still in hospital
Still in hospital
Still in hospital
Still in hospital
Still in hospital
Still in hospital
Pulmonary embolism
Not assessed
Yes
No
Not assessed
No
Yes
Not assessed
No
Not assessed
F: female; M: male; LVEF: left ventricular ejection fraction; NA: not available; RV: right ventricular; HTN: hypertension; chest CT: high CT probability of COVID-19 infection; DAPT: dual antiplatelet therapy; NP swab: positive nasopharyngeal swab; MI: myocardial infarction; PE: pulmonary embolism; AC: anticoagulant (add or modify anticoagulation regimen); RA: right atrial; Resp. distress: respiratory distress; NFH: nonfractioned heparin; CVD: cardiovascular disease; FP: filling pressures; ß bloq: beta bloquers. #Evolution: 1 discharge (to home or rehabilitation); 2 deceased; 3 still in hospital on 17/04/2020 (at the date of writing this manuscript).
